Gsa Capital Partners LLP Sana Biotechnology, Inc. Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	BUY	$5.23 - $10.44 $776,759 - $1.55 Million	148,520 Added 410.19%	184,728 $1.01 Million
Q1 2024 May 03, 2024	SELL	$4.2 - $11.27 $557,604 - $1.5 Million	-132,763 Reduced 78.57%	36,208 $362,000
Q4 2023 Feb 16, 2024	SELL	$2.8 - $4.55 $1.04 Million - $1.69 Million	-371,279 Reduced 68.72%	168,971 $689,000
Q3 2023 Nov 15, 2023	BUY	$3.77 - $6.23 $2.04 Million - $3.37 Million	540,250 New	540,250 $2.09 Million
Q1 2023 May 12, 2023	SELL	$3.11 - $4.92 $194,129 - $307,111	-62,421 Reduced 19.04%	265,372 $867,000
Q4 2022 Feb 13, 2023	BUY	$3.19 - $6.46 $417,303 - $845,071	130,816 Added 66.41%	327,793 $1.3 Million
Q3 2022 Nov 14, 2022	BUY	$5.58 - $9.04 $567,301 - $919,069	101,667 Added 106.67%	196,977 $1.18 Million
Q2 2022 Aug 09, 2022	SELL	$4.12 - $9.35 $168,075 - $381,433	-40,795 Reduced 29.97%	95,310 $613,000
Q1 2022 May 11, 2022	BUY	$5.24 - $15.58 $713,190 - $2.12 Million	136,105 New	136,105 $1.12 Million

176

121M

1.87M

1.48M

Ticker SANA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 190,232,000
Market Cap $569M
Description
Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.